ibiotherapy.com
Oct 25, 2024, 13:37
Bringing the Promise of Immunotherapy to More Patients – Cancer Research Institute
Cancer Research Institute shared a post on LinkedIn:
“The Cancer Research Institute’s investment in research is making a difference and expanding the impact of immunotherapy, with 29 cancers now treatable using these approaches. Over the past year, there have been 13 new FDA approvals for immunotherapy treatments, covering 10 different drugs and 11 types of cancer.
Together, we are supporting groundbreaking discoveries, bringing hope to patients, and redefining the future of cancer treatment.
Continue to explore our impact.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18